{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"mecasermin","name":"Mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":32,"objects":{"clinicaltrials-gov-nct00516386-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00516386-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct00516386-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00516386-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00516386-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct00516386-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct00516386-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2021-11-18","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00516386","sourceIds":["ctg-observation-nct00516386-2021-11-18-161df275078b"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00516386 at 2026-11-16T17:35:13.282Z. Its registry update date was 2021-11-18, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct00516386-2021-11-18-161df275078b"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00516386 at 2026-11-16T17:35:13.282Z. Its registry update date was 2021-11-18, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct00516386-2021-11-18-161df275078b"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00516386-2021-11-18-161df275078b"]}],"sources":[{"id":"ctg-observation-nct00516386-2021-11-18-161df275078b","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00516386 · retained source version 2021-11-18:161df275078b6453f330678694d865b2c26c0955ac25340f0ca6ca6651e9f1da","url":"https://clinicaltrials.gov/study/NCT00516386"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0000a8589f7d4a078947aeaae1df50ca4da1346f56fbc6192d4dcbc4b168fb0f","tierARecordSha256":"d2a02f324e7f762721b05915d34248a3598c649bd624924bde22b8c7f6b70a80"},"integrity":{"algorithm":"sha256","contentSha256":"aad1d83917321c96451f91812c6426a8353d3a2b5960c055715ec58c50ac08e0"}},"clinicaltrials-gov-nct00571727-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00571727-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct00571727-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00571727-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00571727-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct00571727-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct00571727-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2023-07-06","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00571727","sourceIds":["ctg-observation-nct00571727-2023-07-06-9fc20b4b335d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00571727 at 2026-11-16T17:35:13.282Z. Its registry update date was 2023-07-06, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct00571727-2023-07-06-9fc20b4b335d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00571727 at 2026-11-16T17:35:13.282Z. Its registry update date was 2023-07-06, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct00571727-2023-07-06-9fc20b4b335d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00571727-2023-07-06-9fc20b4b335d"]}],"sources":[{"id":"ctg-observation-nct00571727-2023-07-06-9fc20b4b335d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00571727 · retained source version 2023-07-06:9fc20b4b335d459dd7fb556240d955cc392344d567abf48a53aea8e0fd200624","url":"https://clinicaltrials.gov/study/NCT00571727"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"76cd9f84128850bbd17b10dea918abe6a44122a6a4bec037627143b9bfd4a2c5","tierARecordSha256":"5f397394f193430973a8c26263768ec96a9707bfeaee863d634999dbce538def"},"integrity":{"algorithm":"sha256","contentSha256":"6fa02f97774b9fd52798f21fc45ec6fe4b229f533f72605bb6ab42bbe1e729a8"}},"clinicaltrials-gov-nct00903110-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00903110-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct00903110-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00903110-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00903110-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct00903110-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct00903110-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2026-02-06","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00903110","sourceIds":["ctg-observation-nct00903110-2026-02-06-c480897dc98f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00903110 at 2026-11-16T17:35:13.282Z. Its registry update date was 2026-02-06, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct00903110-2026-02-06-c480897dc98f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00903110 at 2026-11-16T17:35:13.282Z. Its registry update date was 2026-02-06, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct00903110-2026-02-06-c480897dc98f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00903110-2026-02-06-c480897dc98f"]}],"sources":[{"id":"ctg-observation-nct00903110-2026-02-06-c480897dc98f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00903110 · retained source version 2026-02-06:c480897dc98f57911b175f46a2e4e0a644c599627c60b9874577d30e6ef226ef","url":"https://clinicaltrials.gov/study/NCT00903110"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5e4b6f74ca9a3b818c3362903f7614fc120e0b9c1e453dad85bbb23c6f77a1a6","tierARecordSha256":"4bb55419c7adf818be84b47c0c6c6832ae898cb2567330721649bd7c6153c6c1"},"integrity":{"algorithm":"sha256","contentSha256":"fd9e74ce5ef749a5dd64dda9f99d5e96b3709b124a5a9b80e75164a80909d3e1"}},"clinicaltrials-gov-nct01406444-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01406444-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct01406444-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01406444-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01406444-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01406444-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct01406444-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2020-07-17","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01406444","sourceIds":["ctg-observation-nct01406444-2020-07-17-62fbd8cb4088"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01406444 at 2026-11-16T17:35:13.282Z. Its registry update date was 2020-07-17, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01406444-2020-07-17-62fbd8cb4088"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01406444 at 2026-11-16T17:35:13.282Z. Its registry update date was 2020-07-17, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01406444-2020-07-17-62fbd8cb4088"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01406444-2020-07-17-62fbd8cb4088"]}],"sources":[{"id":"ctg-observation-nct01406444-2020-07-17-62fbd8cb4088","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01406444 · retained source version 2020-07-17:62fbd8cb4088eadca6ac67a5185fcc04ece64a40a645f4b621249d4afd3b721c","url":"https://clinicaltrials.gov/study/NCT01406444"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"cb0acc8192d5f033983c4ec1c52192eccfffc094c168dbc00a169d7e535af84c","tierARecordSha256":"1f257e138e562adbde25e2355951563de51b1bec072723e0a8990c6a07ae18ea"},"integrity":{"algorithm":"sha256","contentSha256":"727d122dbf992f3ca562e124149872a3cc919b2a3cd3680839c604add87d5a3b"}},"clinicaltrials-gov-nct01438086-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01438086-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct01438086-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01438086-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01438086-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01438086-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct01438086-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2017-03-30","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01438086","sourceIds":["ctg-observation-nct01438086-2017-03-30-a698438dba77"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01438086 at 2026-11-16T17:35:13.282Z. Its registry update date was 2017-03-30, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01438086-2017-03-30-a698438dba77"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01438086 at 2026-11-16T17:35:13.282Z. Its registry update date was 2017-03-30, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01438086-2017-03-30-a698438dba77"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01438086-2017-03-30-a698438dba77"]}],"sources":[{"id":"ctg-observation-nct01438086-2017-03-30-a698438dba77","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01438086 · retained source version 2017-03-30:a698438dba77e9578620a48aa55abefe031b2a26d4368ae45060cd4e2c794b63","url":"https://clinicaltrials.gov/study/NCT01438086"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c4154096cd9936a028db431ae7a49dcb7e14e33705d6319c0b79ae7e58117ce6","tierARecordSha256":"ce402f8047d1998adc3b440cb5196b939f243bcc734be7e7969d6111684bd065"},"integrity":{"algorithm":"sha256","contentSha256":"d2d02f6b64faddc950587e42807fc5990883aad3fdbf3fe8d07512a6104ddd1a"}},"clinicaltrials-gov-nct01446783-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01446783-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct01446783-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01446783-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01446783-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01446783-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct01446783-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2012-11-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01446783","sourceIds":["ctg-observation-nct01446783-2012-11-20-76d4b5ddf7a9"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01446783 at 2026-11-16T17:35:13.282Z. Its registry update date was 2012-11-20, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01446783-2012-11-20-76d4b5ddf7a9"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01446783 at 2026-11-16T17:35:13.282Z. Its registry update date was 2012-11-20, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01446783-2012-11-20-76d4b5ddf7a9"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01446783-2012-11-20-76d4b5ddf7a9"]}],"sources":[{"id":"ctg-observation-nct01446783-2012-11-20-76d4b5ddf7a9","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01446783 · retained source version 2012-11-20:76d4b5ddf7a975cc7efb325ec3ee623dfff0d57d5f8168589ec264f7dd1ecd7e","url":"https://clinicaltrials.gov/study/NCT01446783"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7d8f25d9dc0f5516a5f8db726f7461cd3f566bcea1fa501e9eb93a42b68f691d","tierARecordSha256":"1a20d6d483c84817a438bee18c4b8fdf5612a9e3220f3b5820e671ffe837f6c5"},"integrity":{"algorithm":"sha256","contentSha256":"f3d01a7fd4595ffc67bf203d7db238898a033933f846aa70e658aaf65a3e0450"}},"clinicaltrials-gov-nct01588093-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01588093-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct01588093-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01588093-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01588093-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01588093-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct01588093-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2012-04-30","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01588093","sourceIds":["ctg-observation-nct01588093-2012-04-30-7fadca67e289"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01588093 at 2026-11-16T17:35:13.282Z. Its registry update date was 2012-04-30, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01588093-2012-04-30-7fadca67e289"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01588093 at 2026-11-16T17:35:13.282Z. Its registry update date was 2012-04-30, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01588093-2012-04-30-7fadca67e289"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01588093-2012-04-30-7fadca67e289"]}],"sources":[{"id":"ctg-observation-nct01588093-2012-04-30-7fadca67e289","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01588093 · retained source version 2012-04-30:7fadca67e2894e7ccf5b91f36a69140e2d5ea2cffb895345752341ac06be765f","url":"https://clinicaltrials.gov/study/NCT01588093"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5ead3699afd409e66b81c95659d6f24b185cea76582bedff31f78762b680f88d","tierARecordSha256":"64aa22dd555e6cf89bd4084ed8713db53563b4d48d9cc88fab56e288ce88f596"},"integrity":{"algorithm":"sha256","contentSha256":"a6bf0e0ccbfb321a89701e0382cc01b23388977ba2ea7dc5e52e117d3b32c860"}},"clinicaltrials-gov-nct01777542-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01777542-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct01777542-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01777542-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01777542-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01777542-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct01777542-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2018-03-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01777542","sourceIds":["ctg-observation-nct01777542-2018-03-26-d58dd1bc2791"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01777542 at 2026-11-16T17:35:13.282Z. Its registry update date was 2018-03-26, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01777542-2018-03-26-d58dd1bc2791"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01777542 at 2026-11-16T17:35:13.282Z. Its registry update date was 2018-03-26, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct01777542-2018-03-26-d58dd1bc2791"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01777542-2018-03-26-d58dd1bc2791"]}],"sources":[{"id":"ctg-observation-nct01777542-2018-03-26-d58dd1bc2791","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01777542 · retained source version 2018-03-26:d58dd1bc2791f1d0d3a9f62e46acff7b37e5c7756274f5900e00c95c752c9e10","url":"https://clinicaltrials.gov/study/NCT01777542"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5877b2524d60fdee0353ffeaff61bdb595a4dc44cfe480971f9d30ed6491364f","tierARecordSha256":"74fa105c0fd6b06f0c3a3ed53fb93aa612c44ff7f8ffe007fa97f68bccbba9d6"},"integrity":{"algorithm":"sha256","contentSha256":"759dab1ea300c56bca205b24f8589e7fd6d2e82c8c276339d48382c9e59fd3df"}},"clinicaltrials-gov-nct02636270-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02636270-mecasermin:v1","objectPathId":"clinicaltrials-gov-nct02636270-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02636270-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct02636270-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct02636270-mecasermin-v1"},"story":{"slug":"clinicaltrials-gov-nct02636270-mecasermin","version":1,"domain":"Clinical trials","dateInSource":"2024-02-28","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02636270","sourceIds":["ctg-observation-nct02636270-2024-02-28-e1a6b44d71b6"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02636270 at 2026-11-16T17:35:13.282Z. Its registry update date was 2024-02-28, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct02636270-2024-02-28-e1a6b44d71b6"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02636270 at 2026-11-16T17:35:13.282Z. Its registry update date was 2024-02-28, and PeptideScanner's reviewed identity mapping was mecasermin.","sourceIds":["ctg-observation-nct02636270-2024-02-28-e1a6b44d71b6"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02636270-2024-02-28-e1a6b44d71b6"]}],"sources":[{"id":"ctg-observation-nct02636270-2024-02-28-e1a6b44d71b6","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02636270 · retained source version 2024-02-28:e1a6b44d71b607aa48aaf2ca91ea4726af1ab3ab4d550e26574007a62ee049e0","url":"https://clinicaltrials.gov/study/NCT02636270"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e2d16ceb270b9138d7e217f0f50b35b468a174da269d14579e159d4a2f7c3029","tierARecordSha256":"dc15876f548a1dc9572ef9669fca277f6be16accc0e73739ca445e2dde2e4143"},"integrity":{"algorithm":"sha256","contentSha256":"0ef8cc2b42498a6b3b90f1ca78ab9f8916450baeefbe56bf30022a9445723f7a"}},"fda-drugs-bla021839-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-bla021839:v1","objectPathId":"fda-drugs-bla021839-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-bla021839/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#fda-drugs-bla021839-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#fda-drugs-bla021839-v1"},"story":{"slug":"fda-drugs-bla021839","version":1,"domain":"Regulatory","dateInSource":"2005-08-30","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application BLA021839","sourceIds":["fda-drugs-bla021839-2005-08-30-24e66bd7490b"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for BLA 021839 with status AP dated 2005-08-30, and names mecasermin recombinant among the application record's active ingredients.","sourceIds":["fda-drugs-bla021839-2005-08-30-24e66bd7490b"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for BLA 021839 with status AP dated 2005-08-30, and names mecasermin recombinant among the application record's active ingredients.","sourceIds":["fda-drugs-bla021839-2005-08-30-24e66bd7490b"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-bla021839-2005-08-30-24e66bd7490b"]}],"sources":[{"id":"fda-drugs-bla021839-2005-08-30-24e66bd7490b","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application BLA021839 · original submission status AP · 2005-08-30 · dataset 2026-11-16","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22BLA021839%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ae92b7732e6248a2c424a490273bbd520e62e21b6e7f103407f0117aaed32084","tierARecordSha256":"24e66bd7490b2186a6c54dd1708a2a147bd758ce0acae31368e49fc0549eb4a4"},"integrity":{"algorithm":"sha256","contentSha256":"a3fc3323bb9883fd735d6b943d3735afad70743fd93abbbbcc772ba1234fd3f5"}},"federal-register-97-10541-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-97-10541:v1","objectPathId":"federal-register-97-10541-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-97-10541/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-97-10541-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#federal-register-97-10541-v1"},"story":{"slug":"federal-register-97-10541","version":1,"domain":"Regulatory","dateInSource":"1997-04-23","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Federal Register notice 97-10541","sourceIds":["federal-register-97-10541-02af51bb5ad0"]},{"id":"summary","text":"The Federal Register published notice 97-10541, attributed to FDA and its parent HHS department, on 1997-04-23. Its official title is “Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.","sourceIds":["federal-register-97-10541-02af51bb5ad0"]},{"id":"paragraph-1","text":"The Federal Register published notice 97-10541, attributed to FDA and its parent HHS department, on 1997-04-23. Its official title is “Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.","sourceIds":["federal-register-97-10541-02af51bb5ad0"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-97-10541-02af51bb5ad0"]}],"sources":[{"id":"federal-register-97-10541-02af51bb5ad0","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 97-10541 · published 1997-04-23 · Advisory Committee; Notice of Meeting","url":"https://www.govinfo.gov/content/pkg/FR-1997-04-23/pdf/97-10541.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b9edc6a5757f2a07b0340ff5a58f0efccf53bf62042acf55bb368264a52fedd4","tierARecordSha256":"02af51bb5ad0c24d57c8837018062c8da842f77ebe3831162224116c570a31e5"},"integrity":{"algorithm":"sha256","contentSha256":"ae0be17835ebd7cd96b39debde0261e128ebdacaea7bd80b1b3eb7b64ee4ad34"}},"federal-register-98-7053-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-98-7053:v1","objectPathId":"federal-register-98-7053-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-98-7053/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-98-7053-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#federal-register-98-7053-v1"},"story":{"slug":"federal-register-98-7053","version":1,"domain":"Regulatory","dateInSource":"1998-03-19","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Federal Register notice 98-7053","sourceIds":["federal-register-98-7053-5116fc69f6a8"]},{"id":"summary","text":"The Federal Register published notice 98-7053, attributed to FDA and its parent HHS department, on 1998-03-19. Its official title is “Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.","sourceIds":["federal-register-98-7053-5116fc69f6a8"]},{"id":"paragraph-1","text":"The Federal Register published notice 98-7053, attributed to FDA and its parent HHS department, on 1998-03-19. Its official title is “Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.","sourceIds":["federal-register-98-7053-5116fc69f6a8"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-98-7053-5116fc69f6a8"]}],"sources":[{"id":"federal-register-98-7053-5116fc69f6a8","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 98-7053 · published 1998-03-19 · Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting","url":"https://www.govinfo.gov/content/pkg/FR-1998-03-19/pdf/98-7053.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b88061cab733fe18d64a418eabe6efbb86f7354c8e92e353cbfe379ecffc57ee","tierARecordSha256":"5116fc69f6a8ef98ca4009ff6150c6578fd0b1c5611d992230e9be9e3935d5a5"},"integrity":{"algorithm":"sha256","contentSha256":"097b79e52db0279444f06ee1649dc5dd1933e1b381492f5d7da51d241667bd86"}},"federal-register-e6-12571-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-e6-12571:v1","objectPathId":"federal-register-e6-12571-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-e6-12571/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-e6-12571-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#federal-register-e6-12571-v1"},"story":{"slug":"federal-register-e6-12571","version":1,"domain":"Regulatory","dateInSource":"2006-08-03","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Federal Register notice E6-12571","sourceIds":["federal-register-e6-12571-9199b0abda2a"]},{"id":"summary","text":"The Federal Register published notice E6-12571, attributed to FDA and its parent HHS department, on 2006-08-03. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IPLEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.","sourceIds":["federal-register-e6-12571-9199b0abda2a"]},{"id":"paragraph-1","text":"The Federal Register published notice E6-12571, attributed to FDA and its parent HHS department, on 2006-08-03. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IPLEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.","sourceIds":["federal-register-e6-12571-9199b0abda2a"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-e6-12571-9199b0abda2a"]}],"sources":[{"id":"federal-register-e6-12571-9199b0abda2a","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice E6-12571 · published 2006-08-03 · Determination of Regulatory Review Period for Purposes of Patent Extension; IPLEX","url":"https://www.govinfo.gov/content/pkg/FR-2006-08-03/pdf/E6-12571.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0ab1e5ad399aa6907660e3cd81b2665d6e68db3924320eb16fb5f8fbbee1d682","tierARecordSha256":"9199b0abda2abeaf580779f24e1ab01826274093785372f4c4185bd3b50987c0"},"integrity":{"algorithm":"sha256","contentSha256":"16022c7bf1c788dde0730e81f48b20f377ac4ba0a1df9b336f9b3057a24ad6f1"}},"federal-register-e6-9138-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-e6-9138:v1","objectPathId":"federal-register-e6-9138-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-e6-9138/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-e6-9138-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#federal-register-e6-9138-v1"},"story":{"slug":"federal-register-e6-9138","version":1,"domain":"Regulatory","dateInSource":"2006-06-13","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Federal Register notice E6-9138","sourceIds":["federal-register-e6-9138-42a090343c34"]},{"id":"summary","text":"The Federal Register published notice E6-9138, attributed to FDA and its parent HHS department, on 2006-06-13. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; INCRELEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.","sourceIds":["federal-register-e6-9138-42a090343c34"]},{"id":"paragraph-1","text":"The Federal Register published notice E6-9138, attributed to FDA and its parent HHS department, on 2006-06-13. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; INCRELEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.","sourceIds":["federal-register-e6-9138-42a090343c34"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-e6-9138-42a090343c34"]}],"sources":[{"id":"federal-register-e6-9138-42a090343c34","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice E6-9138 · published 2006-06-13 · Determination of Regulatory Review Period for Purposes of Patent Extension; INCRELEX","url":"https://www.govinfo.gov/content/pkg/FR-2006-06-13/pdf/E6-9138.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4f57ac793622d886b175dcdacc290260015d1c50f3d9d55fe8a2d7699e5e3c29","tierARecordSha256":"42a090343c347b3800d559abc5996967fbbd00191fa96ae3975e5f3d5e676112"},"integrity":{"algorithm":"sha256","contentSha256":"a9c132cda7d5341f89abaf0db9b601f3b7caef8f9b9581df76ae327cb92fe4f3"}},"pubmed-pmid-10576957-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-10576957-mecasermin:v1","objectPathId":"pubmed-pmid-10576957-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-10576957-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-10576957-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-10576957-mecasermin-v1"},"story":{"slug":"pubmed-pmid-10576957-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2007-11-15","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"USAN Council. List No. 419. New names. Mecasermin.","sourceIds":["pubmed-observation-pmid-10576957-2007-11-15-6ba99c8c02fc"]},{"id":"summary","text":"PubMed lists PMID 10576957 in Clinical pharmacology and therapeutics as Journal Article, with publication-date metadata of 1999-09 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-10576957-2007-11-15-6ba99c8c02fc"]},{"id":"paragraph-1","text":"PubMed lists PMID 10576957 in Clinical pharmacology and therapeutics as Journal Article, with publication-date metadata of 1999-09 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-10576957-2007-11-15-6ba99c8c02fc"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-10576957-2007-11-15-6ba99c8c02fc"]}],"sources":[{"id":"pubmed-observation-pmid-10576957-2007-11-15-6ba99c8c02fc","name":"PubMed","sourceClass":"A","title":"USAN Council. List No. 419. New names. Mecasermin. · retained source version 1:2007-11-15:current:6ba99c8c02fcafbcdaad14bb92e6178d68934c966ee578afc4f5dccac3810e06","url":"https://pubmed.ncbi.nlm.nih.gov/10576957/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f58c8dd417c63213825c1e3fce0647fbe1de241d2b7a60cae491269790904c81","tierARecordSha256":"778a71b71c0fc895250f00d8f2674f0422859247aa06b862bae1371ee73840a4"},"integrity":{"algorithm":"sha256","contentSha256":"656c53c8b1b125ee5e04ea6f8423c5013e9daa9b5fda258ddbdc3b2c1ebaf27f"}},"pubmed-pmid-15777106-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-15777106-mecasermin:v1","objectPathId":"pubmed-pmid-15777106-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-15777106-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-15777106-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-15777106-mecasermin-v1"},"story":{"slug":"pubmed-pmid-15777106-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2018-10-25","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.","sourceIds":["pubmed-observation-pmid-15777106-2018-10-25-c7f7c7772e09"]},{"id":"summary","text":"PubMed lists PMID 15777106 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2005 (year precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15777106-2018-10-25-c7f7c7772e09"]},{"id":"paragraph-1","text":"PubMed lists PMID 15777106 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2005 (year precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15777106-2018-10-25-c7f7c7772e09"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-15777106-2018-10-25-c7f7c7772e09"]}],"sources":[{"id":"pubmed-observation-pmid-15777106-2018-10-25-c7f7c7772e09","name":"PubMed","sourceClass":"A","title":"Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3. · retained source version 1:2018-10-25:current:c7f7c7772e09a4b6abf45ff3522b4f75e6b5d21700a44944145999bcec8c1ba4","url":"https://pubmed.ncbi.nlm.nih.gov/15777106/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fc84afa56434b700bd093c769ebc5deb8fc1ce879d486885a462fd4c27113f1a","tierARecordSha256":"869a28bda8f5c9ab8ed637bd72ad215a286b3efc30895c12ed85da9a1bfeee5a"},"integrity":{"algorithm":"sha256","contentSha256":"d502107a610f455a73b91cd1ed7cfa1cc0f6a95516d3869e08f7f3b673ac6372"}},"pubmed-pmid-16625824-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-16625824-mecasermin:v1","objectPathId":"pubmed-pmid-16625824-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-16625824-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-16625824-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-16625824-mecasermin-v1"},"story":{"slug":"pubmed-pmid-16625824-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2007-11-15","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin Tercica.","sourceIds":["pubmed-observation-pmid-16625824-2007-11-15-6935007fceee"]},{"id":"summary","text":"PubMed lists PMID 16625824 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-16625824-2007-11-15-6935007fceee"]},{"id":"paragraph-1","text":"PubMed lists PMID 16625824 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-16625824-2007-11-15-6935007fceee"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-16625824-2007-11-15-6935007fceee"]}],"sources":[{"id":"pubmed-observation-pmid-16625824-2007-11-15-6935007fceee","name":"PubMed","sourceClass":"A","title":"Mecasermin Tercica. · retained source version 1:2007-11-15:current:6935007fceee11a7e9d1921c19b3c42859a545a095efd7d96e42ada7dcdf1362","url":"https://pubmed.ncbi.nlm.nih.gov/16625824/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"938869ea49b3d1888557f03d956c9b6122250eb8e33c9fc6090d41ddbadd27ab","tierARecordSha256":"c504cd5aef454334ba46d47dc22e4c3990026a9ddd909148acc1cae953954cd9"},"integrity":{"algorithm":"sha256","contentSha256":"bb78bab4211f1f3746c520aa5f0fe83dd11ba1c09b378c95f56dbf023af696d1"}},"pubmed-pmid-17380212-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-17380212-mecasermin:v1","objectPathId":"pubmed-pmid-17380212-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-17380212-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-17380212-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-17380212-mecasermin-v1"},"story":{"slug":"pubmed-pmid-17380212-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2017-04-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin rinfabate.","sourceIds":["pubmed-observation-pmid-17380212-2017-04-27-0687dcfa5df0"]},{"id":"summary","text":"PubMed lists PMID 17380212 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2007-03 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17380212-2017-04-27-0687dcfa5df0"]},{"id":"paragraph-1","text":"PubMed lists PMID 17380212 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2007-03 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17380212-2017-04-27-0687dcfa5df0"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-17380212-2017-04-27-0687dcfa5df0"]}],"sources":[{"id":"pubmed-observation-pmid-17380212-2017-04-27-0687dcfa5df0","name":"PubMed","sourceClass":"A","title":"Mecasermin rinfabate. · retained source version 1:2017-04-27:current:0687dcfa5df0a25e46871846e58062a7140db69aa229403d06a895a8e0d9461d","url":"https://pubmed.ncbi.nlm.nih.gov/17380212/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"73891668cde961c7d1f0da3d7f541a400374cc63f79c4be6341ec9a9620f7035","tierARecordSha256":"1792fc412dbed721a6a02f8ddc6aa4bab4ac71220b3d2459c98d51eedca234d8"},"integrity":{"algorithm":"sha256","contentSha256":"59a61a1eff03995b9fae267daf0f1f2fa1e135826fae4ccceb701ae5c8c6c855"}},"pubmed-pmid-18363546-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-18363546-mecasermin:v1","objectPathId":"pubmed-pmid-18363546-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-18363546-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-18363546-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-18363546-mecasermin-v1"},"story":{"slug":"pubmed-pmid-18363546-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2019-11-10","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX.","sourceIds":["pubmed-observation-pmid-18363546-2019-11-10-eb8cab9432b5"]},{"id":"summary","text":"PubMed lists PMID 18363546 in Expert opinion on drug metabolism & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2008-03 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18363546-2019-11-10-eb8cab9432b5"]},{"id":"paragraph-1","text":"PubMed lists PMID 18363546 in Expert opinion on drug metabolism & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2008-03 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18363546-2019-11-10-eb8cab9432b5"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-18363546-2019-11-10-eb8cab9432b5"]}],"sources":[{"id":"pubmed-observation-pmid-18363546-2019-11-10-eb8cab9432b5","name":"PubMed","sourceClass":"A","title":"Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX. · retained source version 1:2019-11-10:current:eb8cab9432b5bcee4fa662489cc858eddd921d87a96a489b284d2768a2657b2c","url":"https://pubmed.ncbi.nlm.nih.gov/18363546/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"dbf94bfff12ff0e223991eac19bfb9ca5be5fab7dcf4ae8648dad85ba6b9ece1","tierARecordSha256":"0df7507fa98bc770604cbfbc3d6c124e753c942cc278a1f7a8db809577546607"},"integrity":{"algorithm":"sha256","contentSha256":"b4ab5db51adba1b5ada0918a31311481eee3286c0a9d6f67804a36c9c40da020"}},"pubmed-pmid-18481900-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-18481900-mecasermin:v1","objectPathId":"pubmed-pmid-18481900-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-18481900-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-18481900-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-18481900-mecasermin-v1"},"story":{"slug":"pubmed-pmid-18481900-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2022-03-31","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin.","sourceIds":["pubmed-observation-pmid-18481900-2022-03-31-9af075e9cb87"]},{"id":"summary","text":"PubMed lists PMID 18481900 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, Review, with publication-date metadata of 2008 (year precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18481900-2022-03-31-9af075e9cb87"]},{"id":"paragraph-1","text":"PubMed lists PMID 18481900 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, Review, with publication-date metadata of 2008 (year precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18481900-2022-03-31-9af075e9cb87"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-18481900-2022-03-31-9af075e9cb87"]}],"sources":[{"id":"pubmed-observation-pmid-18481900-2022-03-31-9af075e9cb87","name":"PubMed","sourceClass":"A","title":"Mecasermin. · retained source version 1:2022-03-31:current:9af075e9cb87a59b4dc681de52ada470d08feca429b64dd7e7df5526f80af906","url":"https://pubmed.ncbi.nlm.nih.gov/18481900/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"52a60fc0518ac5ab58422bd69827c690ba17c611842bab9a5f8fcedf6f11ced2","tierARecordSha256":"6df1ff0819d09b14bfa747dc84a159c4e54a3e331ac7c705ae4dde2bf197e92f"},"integrity":{"algorithm":"sha256","contentSha256":"460bb006ef981e1bc9ca0ebf6cc073b81d06da79cd291f7164c934c0302d42ea"}},"pubmed-pmid-19198769-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19198769-mecasermin:v1","objectPathId":"pubmed-pmid-19198769-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19198769-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19198769-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-19198769-mecasermin-v1"},"story":{"slug":"pubmed-pmid-19198769-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2012-11-15","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin (recombinant human insulin-like growth factor I).","sourceIds":["pubmed-observation-pmid-19198769-2012-11-15-f4a1ecd4abb6"]},{"id":"summary","text":"PubMed lists PMID 19198769 in Advances in therapy as Journal Article, Review, with publication-date metadata of 2009-01-28 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19198769-2012-11-15-f4a1ecd4abb6"]},{"id":"paragraph-1","text":"PubMed lists PMID 19198769 in Advances in therapy as Journal Article, Review, with publication-date metadata of 2009-01-28 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19198769-2012-11-15-f4a1ecd4abb6"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19198769-2012-11-15-f4a1ecd4abb6"]}],"sources":[{"id":"pubmed-observation-pmid-19198769-2012-11-15-f4a1ecd4abb6","name":"PubMed","sourceClass":"A","title":"Mecasermin (recombinant human insulin-like growth factor I). · retained source version 1:2012-11-15:current:f4a1ecd4abb6cd2d34e495904470222798571edb0e5b3d01b9ecf6d6ea7bca94","url":"https://pubmed.ncbi.nlm.nih.gov/19198769/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"52bea775ea01de3a868886964ee3547fa99082d332c0fad1ae6c0114e82f8c43","tierARecordSha256":"a0ea914f54e5d249df850f12706a9556ccc963cc65a87d575b12b37733ff98cd"},"integrity":{"algorithm":"sha256","contentSha256":"8cd2930ac3710f3a4c5fee2f9544732d10110c821e137d221be07492d254ef36"}},"pubmed-pmid-19663134-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19663134-mecasermin:v1","objectPathId":"pubmed-pmid-19663134-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19663134-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19663134-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-19663134-mecasermin-v1"},"story":{"slug":"pubmed-pmid-19663134-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2009-08-11","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Allergic reaction to mecasermin.","sourceIds":["pubmed-observation-pmid-19663134-2009-08-11-2b30cd4ab623"]},{"id":"summary","text":"PubMed lists PMID 19663134 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Case Reports, Letter, with publication-date metadata of 2009-07 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19663134-2009-08-11-2b30cd4ab623"]},{"id":"paragraph-1","text":"PubMed lists PMID 19663134 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Case Reports, Letter, with publication-date metadata of 2009-07 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19663134-2009-08-11-2b30cd4ab623"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19663134-2009-08-11-2b30cd4ab623"]}],"sources":[{"id":"pubmed-observation-pmid-19663134-2009-08-11-2b30cd4ab623","name":"PubMed","sourceClass":"A","title":"Allergic reaction to mecasermin. · retained source version 1:2009-08-11:current:2b30cd4ab6230a7e3343ce9bfab1d8cd889ceff88b49ca2ac4cba08ba2ffcc2e","url":"https://pubmed.ncbi.nlm.nih.gov/19663134/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b4f12751d95886145a74fdbf11e354fb9dca20206fce1ee636701d38503bebd0","tierARecordSha256":"2e1c49d11feb3fa0866e3417cb29166721bbf34eefbf7d18364432b91e635c89"},"integrity":{"algorithm":"sha256","contentSha256":"f416556440946d096c638fbc02fc55f27dec3d9d90b7a9c487145c0d3401e28f"}},"pubmed-pmid-19707272-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19707272-mecasermin:v1","objectPathId":"pubmed-pmid-19707272-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19707272-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19707272-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-19707272-mecasermin-v1"},"story":{"slug":"pubmed-pmid-19707272-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2022-03-10","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency.","sourceIds":["pubmed-observation-pmid-19707272-2022-03-10-b48363726a05"]},{"id":"summary","text":"PubMed lists PMID 19707272 in Therapeutics and clinical risk management as Journal Article, with publication-date metadata of 2009-08-03 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19707272-2022-03-10-b48363726a05"]},{"id":"paragraph-1","text":"PubMed lists PMID 19707272 in Therapeutics and clinical risk management as Journal Article, with publication-date metadata of 2009-08-03 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19707272-2022-03-10-b48363726a05"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19707272-2022-03-10-b48363726a05"]}],"sources":[{"id":"pubmed-observation-pmid-19707272-2022-03-10-b48363726a05","name":"PubMed","sourceClass":"A","title":"Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency. · retained source version 1:2022-03-10:current:b48363726a057de0577fc02e0c91ef1cf943198157d22b34a25ffdfcd8e1a5de","url":"https://pubmed.ncbi.nlm.nih.gov/19707272/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"bb555c76445795acc88de9a839de42e3f7a527a5e64093e2059378c5467ed6b1","tierARecordSha256":"6d5709e131e53acd104a21ad713b8a4dde94ae87ce9e36bbf4a9e83fb6a1f2c3"},"integrity":{"algorithm":"sha256","contentSha256":"2fb51a497dcc5ad994552372cdf6a3763b400db300ef1cca66127a1da9da3b9f"}},"pubmed-pmid-22986916-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-22986916-mecasermin:v1","objectPathId":"pubmed-pmid-22986916-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-22986916-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-22986916-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-22986916-mecasermin-v1"},"story":{"slug":"pubmed-pmid-22986916-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2016-05-19","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Postprandial hyperglycemia corrected by IGF-I (Increlex®) in Laron syndrome.","sourceIds":["pubmed-observation-pmid-22986916-2016-05-19-d71624450ea8"]},{"id":"summary","text":"PubMed lists PMID 22986916 in Hormone research in paediatrics as Case Reports, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-09-13 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22986916-2016-05-19-d71624450ea8"]},{"id":"paragraph-1","text":"PubMed lists PMID 22986916 in Hormone research in paediatrics as Case Reports, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-09-13 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22986916-2016-05-19-d71624450ea8"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-22986916-2016-05-19-d71624450ea8"]}],"sources":[{"id":"pubmed-observation-pmid-22986916-2016-05-19-d71624450ea8","name":"PubMed","sourceClass":"A","title":"Postprandial hyperglycemia corrected by IGF-I (Increlex®) in Laron syndrome. · retained source version 1:2016-05-19:current:d71624450ea8f7b2b9b2ea9d833c0f17292de76d4b4c3472a0a90fbfa5c16d93","url":"https://pubmed.ncbi.nlm.nih.gov/22986916/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1ad98483043f4911531986c8003513e4d1a42e289c2344d5a9eddd0bfd98e851","tierARecordSha256":"27e4c51d92604bcbe42f5cc728270765140e4058361f5526336754b311a3ade7"},"integrity":{"algorithm":"sha256","contentSha256":"77ea2888d821f3327fd447f88967094e4b74f5b6b768bbe7d8fa318e2fbe9078"}},"pubmed-pmid-25843163-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-25843163-mecasermin:v1","objectPathId":"pubmed-pmid-25843163-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-25843163-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-25843163-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-25843163-mecasermin-v1"},"story":{"slug":"pubmed-pmid-25843163-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2015-05-29","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Desensitization to mecasermin in an insulin-like growth factor 1-deficient patient.","sourceIds":["pubmed-observation-pmid-25843163-2015-05-29-4b8030f51ff0"]},{"id":"summary","text":"PubMed lists PMID 25843163 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Case Reports, Letter, with publication-date metadata of 2015-04-03 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25843163-2015-05-29-4b8030f51ff0"]},{"id":"paragraph-1","text":"PubMed lists PMID 25843163 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Case Reports, Letter, with publication-date metadata of 2015-04-03 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25843163-2015-05-29-4b8030f51ff0"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-25843163-2015-05-29-4b8030f51ff0"]}],"sources":[{"id":"pubmed-observation-pmid-25843163-2015-05-29-4b8030f51ff0","name":"PubMed","sourceClass":"A","title":"Desensitization to mecasermin in an insulin-like growth factor 1-deficient patient. · retained source version 1:2015-05-29:current:4b8030f51ff0988406e5e7359f651f060c4864cfec2b4100bdea57391f23b2a2","url":"https://pubmed.ncbi.nlm.nih.gov/25843163/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7eef38d077cd6ed218644c3920ec1aaefcbfe93742a3d59af77b39b888187d21","tierARecordSha256":"1d16d84950515969b28627cf3243dd4a7fd99f046c8049b08237b301fd7045d7"},"integrity":{"algorithm":"sha256","contentSha256":"2234cd3b0a927372613a450ba38870dc2284a6dbf4c9a0691b33f2cd27f2721f"}},"pubmed-pmid-26339260-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-26339260-mecasermin:v1","objectPathId":"pubmed-pmid-26339260-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-26339260-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-26339260-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-26339260-mecasermin-v1"},"story":{"slug":"pubmed-pmid-26339260-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2020-09-30","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Recombinant production of mecasermin in E. coli expression system.","sourceIds":["pubmed-observation-pmid-26339260-2020-09-30-6ac59de38963"]},{"id":"summary","text":"PubMed lists PMID 26339260 in Research in pharmaceutical sciences as Journal Article, with publication-date metadata of 2014 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-26339260-2020-09-30-6ac59de38963"]},{"id":"paragraph-1","text":"PubMed lists PMID 26339260 in Research in pharmaceutical sciences as Journal Article, with publication-date metadata of 2014 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-26339260-2020-09-30-6ac59de38963"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-26339260-2020-09-30-6ac59de38963"]}],"sources":[{"id":"pubmed-observation-pmid-26339260-2020-09-30-6ac59de38963","name":"PubMed","sourceClass":"A","title":"Recombinant production of mecasermin in E. coli expression system. · retained source version 1:2020-09-30:current:6ac59de38963f80c3a4540c278b395703f997de50ead6f8f2cf01703c6fa3b93","url":"https://pubmed.ncbi.nlm.nih.gov/26339260/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3f8ad21c52e29903891964be8f9a02ed7b960fc9d9b772e28f32a76ee457d90d","tierARecordSha256":"b72c0229f1588b2b69f397f5dab60f2915d13208e7f1fbeb983b288242fd0b6a"},"integrity":{"algorithm":"sha256","contentSha256":"f0baf26cc7fd6e971068a494b0b9bfa26e81f3140a041a9d82cdc177caecc136"}},"pubmed-pmid-29695048-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29695048-mecasermin:v1","objectPathId":"pubmed-pmid-29695048-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29695048-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-29695048-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-29695048-mecasermin-v1"},"story":{"slug":"pubmed-pmid-29695048-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2019-01-24","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.","sourceIds":["pubmed-observation-pmid-29695048-2019-01-24-33fe404f8347"]},{"id":"summary","text":"PubMed lists PMID 29695048 in International journal of molecular sciences as Case Reports, Journal Article, Review, with publication-date metadata of 2018-04-24 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29695048-2019-01-24-33fe404f8347"]},{"id":"paragraph-1","text":"PubMed lists PMID 29695048 in International journal of molecular sciences as Case Reports, Journal Article, Review, with publication-date metadata of 2018-04-24 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29695048-2019-01-24-33fe404f8347"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29695048-2019-01-24-33fe404f8347"]}],"sources":[{"id":"pubmed-observation-pmid-29695048-2019-01-24-33fe404f8347","name":"PubMed","sourceClass":"A","title":"Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature. · retained source version 1:2019-01-24:current:33fe404f83475e7c61060dd57d873970412ee4dbde0d702a3080a78b7c6747a2","url":"https://pubmed.ncbi.nlm.nih.gov/29695048/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fb967386b662e754d1340644716294b16a4722bedfd715a9e211a9377702ec03","tierARecordSha256":"e32b16203f96c3554619d9f2bf55e5f44d266f686b96539e0e0af44d09478c4c"},"integrity":{"algorithm":"sha256","contentSha256":"d106b1f5a44337473c696d1d1d9b8ccdd6e0e9201ed98552efcc0168684862ca"}},"pubmed-pmid-29750649-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29750649-mecasermin:v1","objectPathId":"pubmed-pmid-29750649-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29750649-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-29750649-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-29750649-mecasermin-v1"},"story":{"slug":"pubmed-pmid-29750649-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2021-02-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Cardiac examination in children with Laron syndrome undergoing mecasermin therapy.","sourceIds":["pubmed-observation-pmid-29750649-2021-02-13-38a182b2c7cd"]},{"id":"summary","text":"PubMed lists PMID 29750649 in Journal of pediatric endocrinology & metabolism : JPEM as Case Reports, Journal Article, with publication-date metadata of 2018-06-27 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29750649-2021-02-13-38a182b2c7cd"]},{"id":"paragraph-1","text":"PubMed lists PMID 29750649 in Journal of pediatric endocrinology & metabolism : JPEM as Case Reports, Journal Article, with publication-date metadata of 2018-06-27 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29750649-2021-02-13-38a182b2c7cd"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29750649-2021-02-13-38a182b2c7cd"]}],"sources":[{"id":"pubmed-observation-pmid-29750649-2021-02-13-38a182b2c7cd","name":"PubMed","sourceClass":"A","title":"Cardiac examination in children with Laron syndrome undergoing mecasermin therapy. · retained source version 1:2021-02-13:current:38a182b2c7cd8b036d18823704710106d0296f1c2581d13606ee1dc6af094e5f","url":"https://pubmed.ncbi.nlm.nih.gov/29750649/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e5b18d7f484a45f24aaa62289f45e395d64ed3e6973701ba176c63a96ff268ac","tierARecordSha256":"7ef6f0d7caca5465417851e29ee4805e350d5a42b02575a6896db6f58e199ec7"},"integrity":{"algorithm":"sha256","contentSha256":"bcab93ccd40caa0da4707d88692f1b7e1b32a13d411a1c43231687c6a024e7a3"}},"pubmed-pmid-32692415-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-32692415-mecasermin:v1","objectPathId":"pubmed-pmid-32692415-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-32692415-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-32692415-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-32692415-mecasermin-v1"},"story":{"slug":"pubmed-pmid-32692415-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2021-09-29","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Efficient process development for high-level production, purification, formulation, and characterization of recombinant mecasermin in Escherichia coli.","sourceIds":["pubmed-observation-pmid-32692415-2021-09-29-6f46addb793d"]},{"id":"summary","text":"PubMed lists PMID 32692415 in Biotechnology and applied biochemistry as Journal Article, with publication-date metadata of 2020-08-07 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-32692415-2021-09-29-6f46addb793d"]},{"id":"paragraph-1","text":"PubMed lists PMID 32692415 in Biotechnology and applied biochemistry as Journal Article, with publication-date metadata of 2020-08-07 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-32692415-2021-09-29-6f46addb793d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-32692415-2021-09-29-6f46addb793d"]}],"sources":[{"id":"pubmed-observation-pmid-32692415-2021-09-29-6f46addb793d","name":"PubMed","sourceClass":"A","title":"Efficient process development for high-level production, purification, formulation, and characterization of recombinant mecasermin in Escherichia coli. · retained source version 1:2021-09-29:current:6f46addb793dc5b4aca078c19694d197dfafcb11233c4718c6aa023ba4065049","url":"https://pubmed.ncbi.nlm.nih.gov/32692415/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a9645ae401ec7a3d8f03c5508f6e3c559e6a80b1c93a9028ee53b670bd262148","tierARecordSha256":"6def6751dcd5ec6290ef365fa30a509171a942d2d9b59089acf44c0f8c53eaa8"},"integrity":{"algorithm":"sha256","contentSha256":"912c521caaebf296222b2de0494c133126de7d3633ae1e58ea8889885cb1366d"}},"pubmed-pmid-36269524-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-36269524-mecasermin:v1","objectPathId":"pubmed-pmid-36269524-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-36269524-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-36269524-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-36269524-mecasermin-v1"},"story":{"slug":"pubmed-pmid-36269524-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2026-01-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment.","sourceIds":["pubmed-observation-pmid-36269524-2026-01-27-7ec762672033"]},{"id":"summary","text":"PubMed lists PMID 36269524 in Stem cell reviews and reports as Journal Article, with publication-date metadata of 2022-10-21 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36269524-2026-01-27-7ec762672033"]},{"id":"paragraph-1","text":"PubMed lists PMID 36269524 in Stem cell reviews and reports as Journal Article, with publication-date metadata of 2022-10-21 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36269524-2026-01-27-7ec762672033"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-36269524-2026-01-27-7ec762672033"]}],"sources":[{"id":"pubmed-observation-pmid-36269524-2026-01-27-7ec762672033","name":"PubMed","sourceClass":"A","title":"Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment. · retained source version 1:2026-01-27:current:7ec76267203350b36928e36b618105498b1c230a81c7272d094bd1e53d4dcac2","url":"https://pubmed.ncbi.nlm.nih.gov/36269524/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"72ed7a90ff626741b56dceb6b84870f7cf25a1636c24c44894a634300b3094b0","tierARecordSha256":"2133b9eea2ca7efbb836cd774ec3b4d95966fb2d400db1af1ef3b72f6fe258e9"},"integrity":{"algorithm":"sha256","contentSha256":"2029be088baa5c8f641d34420e97aaa482c9259c96c026a0a194b9e0e3371381"}},"pubmed-pmid-36479333-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-36479333-mecasermin:v1","objectPathId":"pubmed-pmid-36479333-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-36479333-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-36479333-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-36479333-mecasermin-v1"},"story":{"slug":"pubmed-pmid-36479333-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2022-12-10","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin for primary insulin-like growth factor-1 deficiency.","sourceIds":["pubmed-observation-pmid-36479333-2022-12-10-f4a9f302877d"]},{"id":"summary","text":"PubMed lists PMID 36479333 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2022-12-01 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36479333-2022-12-10-f4a9f302877d"]},{"id":"paragraph-1","text":"PubMed lists PMID 36479333 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2022-12-01 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36479333-2022-12-10-f4a9f302877d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-36479333-2022-12-10-f4a9f302877d"]}],"sources":[{"id":"pubmed-observation-pmid-36479333-2022-12-10-f4a9f302877d","name":"PubMed","sourceClass":"A","title":"Mecasermin for primary insulin-like growth factor-1 deficiency. · retained source version 1:2022-12-10:current:f4a9f302877d07e631433757f17363028677b6c9a21e5d0d62789c46fd2bc3ab","url":"https://pubmed.ncbi.nlm.nih.gov/36479333/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"79f05b52da98dce18ad4f6c4c1ae4b783270ec1d39c3d22305f66a626d836d08","tierARecordSha256":"60b3ad5d5ad69e909a6bd228c1e877d75cfd6c89506f51462ca6eb44ea7c5bc6"},"integrity":{"algorithm":"sha256","contentSha256":"3cadca40b053b2e6edf07bd11b3e392d3981b565044ecd878ade95d4baa9d800"}},"pubmed-pmid-41174329-mecasermin-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41174329-mecasermin:v1","objectPathId":"pubmed-pmid-41174329-mecasermin-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41174329-mecasermin/","json":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-41174329-mecasermin-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-41174329-mecasermin-v1"},"story":{"slug":"pubmed-pmid-41174329-mecasermin","version":1,"domain":"Literature metadata","dateInSource":"2026-11-05","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["mecasermin"],"peptides":[{"slug":"mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"}]},"claims":[{"id":"headline","text":"Mecasermin for the treatment of Rett Syndrome: a systematic review.","sourceIds":["pubmed-observation-pmid-41174329-2026-11-05-3ad54ec93eaf"]},{"id":"summary","text":"PubMed lists PMID 41174329 in Neurogenetics as Journal Article, Systematic Review, with publication-date metadata of 2025-11-01 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41174329-2026-11-05-3ad54ec93eaf"]},{"id":"paragraph-1","text":"PubMed lists PMID 41174329 in Neurogenetics as Journal Article, Systematic Review, with publication-date metadata of 2025-11-01 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41174329-2026-11-05-3ad54ec93eaf"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41174329-2026-11-05-3ad54ec93eaf"]}],"sources":[{"id":"pubmed-observation-pmid-41174329-2026-11-05-3ad54ec93eaf","name":"PubMed","sourceClass":"A","title":"Mecasermin for the treatment of Rett Syndrome: a systematic review. · retained source version 1:2026-11-05:current:3ad54ec93eafade66be50cb14b98f13df1c80c9762ddf7e2292526ffd1b8416e","url":"https://pubmed.ncbi.nlm.nih.gov/41174329/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3a3be21e3e5135a613266dfb990b99cf1f24cf6eb624432c31195eddbc89b7eb","tierARecordSha256":"5a42bed9b20f36e3db769cf17edaca7fe6d53c073aa4a3637da2a6f0b51ce361"},"integrity":{"algorithm":"sha256","contentSha256":"2a0d5b452043aacdd5c18113b5e93bf62e48d7b1b0d116cc3fb7f49306850090"}}}}
